• Go to content
  • Go to search
  • Go to menu
République Française. Liberté, Égalité, Fraternité.
Site de l’ANRS, Maladie infectieuses émergentes — Inserm
  • Newsroom
  • Publications
  • Press room
  • Participant area
  • Français
  • English
Submit a project
  • Who are we?
    Who are we?

    ANRS Infectious emerging diseases (MIE), autonomous agency of Inserm, facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases.

    • The agency in brief

      A central role in infectious diseases research for over 35 years

    • Mission and strategy

      Supporting research to prevent, understand and treat infectious diseases

    • Facilitating, funding and structuring research

      ANRS MIE three majors levels of action

    • Organisation and governance

      ANRS MIE is an agency operating under the specific status of an autonomous agency within Inserm.

    • Scientific commitments and values

      Patient associations, next generation of scientists, quality and ethical approach, open science

  • Research
    Research

    Our agency funds, coordinates, evaluates and facilitates research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases.

    • Diseases and pathogens

      Learn more about the diseases and pathogens covered by our research

    • Research projects

      Information on the projects we fund

    • Scientific facilitation groups

      Our workgroups bring together researchers and representatives of civil society

    • Innovation Committee

      Guiding and advising innovative project leaders

  • Infrastructures
    Infrastructures

    The agency supports a number of research platforms and networks to federate and help shape research in its field

    • Research platforms

      National and international research platforms supported by the agency and designed for the scientific community

    • Thematic networks

      Clinical research networks and networks of young researchers

    • Data and samples

      Access to data and biological collections from research promoted by the agency

  • Partnerships
    Partnerships

    The agency is a member of various networks and forges partnerships with national and international associations, organisations and initiatives

    • The ANRS Emerging infectious diseases International Network

      Partner sites, international global health research platforms, ad hoc partnerships

    • Partnerships and initiatives

      WHO, Ministry of Europe and Foreign Affairs, Global Health EDCTP3 Joint Undertaking, structuring networks

    • International structuring projects

      Strategic international projects and capacity-building programmes

    • WHO filovirus CORC

      Fighting epidemics: ANRS MIE leads WHO filovirus CORC

    • Patient associations

      Collaboration with community stakeholders

  • Funding
    Funding

    Each year, the agency offers two calls for generic projects and calls for thematic projects. Some are jointly carried out with other research players

    • All calls for proposals

      Agency's current, forthcoming and completed calls for proposals

    • Winning projects and candidates

      Find out the list of calls for projects previously funded by the agency

    • Start programme

      Find out the Start programme, here to support and guide the next generation of scientific researchers

  • Disease Outbreak
    Disease Outbreak

    ANRS MIE is at the forefront of crisis preparedness and response.

    • Outbreak Response programme

      Facilitation and watch procedure for responding to emerging or re-emerging epidemics.

    • Filovirus (Ebola) Outbreak Response Unit

      This Outbreak Response Unit for several diseases is active since March 2025.

    • Influenza/Flu Outbreak Response unit

      ANRS MIE continues to follow influenza closely since June 2024.

    • Chikungunya Outbreak Response Unit

      Opened since January 2025 and still active since the detection of one new case in French Guiana in January 2026.

    • Outbreak Response units

      Every Outbreak response units, active or inactive.

  • Newsletter
    Newsletter
  • Newsroom
  • Publications
  • Press room
  • Participant area
    • Français
    • English

Submit a project

Search

  1. Homepage
  2. Search

Search results

Share:

  • Share on Twitter
  • Share on Linkedin


Type de publication
Diseases
Country
Disciplines
Fields
Type de publication
Issuer
Contract type
Job location
Infection type
Population
Status
Sample

69 results

Trier par


  • News

    Strengthened French–Brazilian scientific collaborations

    The São Paulo Research Foundation (FAPESP), Inserm and ANRS Maladies infectieuses émergentes signed a memorandum of understanding on 29 March 2023 aimed at fostering cooperation in scientific research. This partnership was renewed for a further three-year period on 9 June 2026.

    11 June 2026

  • Press releases

    Bundibugyo Ebola virus outbreak: launch of the EBO-PEP trial to protect high-risk contacts

    14 July 2026

  • Brazil Partner Site

    31 July 2026

  • Cameroon Partner Site

    29 July 2026

  • Vietnam Partner Site

    30 July 2026

  • International structuring projects

    As an operator of capacity-building programmes, one of ANRS MIE's missions is to support strategic international projects. The agency mobilises and coordinates the resources needed for international projects involving French research players and their partners. This new prerogative was initiated...

    06 November 2023

  • The ANRS Emerging infectious diseases International Network

    15 January 2024

  • Press releases

    Final results of the ANRS DOXYVAC STI prevention trial

    05 March 2024

  • Previous
  • 1
  • ...
  • ...
  • 6
  • 7
  • 8
  • 9
  • Suivant
République Française. Liberté, Égalité, Fraternité.
ANRS, Maladie infectieuses émergentes — Inserm
Pratical information
  • Newsroom
  • Contact us
  • Join us
  • Site map
Legal
  • Legal information
  • Personal data and cookies
  • Accessibility